Copyright Reports & Markets. All rights reserved.

Global Infectious Vaccines Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Infectious Vaccines

      • 1.1 Definition of Infectious Vaccines
      • 1.2 Infectious Vaccines Segment by Type
        • 1.2.1 Global Infectious Vaccines Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Preventive vaccine
        • 1.2.3 Therapeutic vaccine
      • 1.3 Infectious Vaccines Segment by Applications
        • 1.3.1 Global Infectious Vaccines Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Adults
        • 1.3.3 Pediatrics
      • 1.4 Global Infectious Vaccines Overall Market
        • 1.4.1 Global Infectious Vaccines Revenue (2014-2025)
        • 1.4.2 Global Infectious Vaccines Production (2014-2025)
        • 1.4.3 North America Infectious Vaccines Status and Prospect (2014-2025)
        • 1.4.4 Europe Infectious Vaccines Status and Prospect (2014-2025)
        • 1.4.5 China Infectious Vaccines Status and Prospect (2014-2025)
        • 1.4.6 Japan Infectious Vaccines Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Infectious Vaccines Status and Prospect (2014-2025)
        • 1.4.8 India Infectious Vaccines Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Infectious Vaccines
      • 2.3 Manufacturing Process Analysis of Infectious Vaccines
      • 2.4 Industry Chain Structure of Infectious Vaccines

      3 Development and Manufacturing Plants Analysis of Infectious Vaccines

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Infectious Vaccines Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Infectious Vaccines
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Infectious Vaccines Production and Capacity Analysis
      • 4.2 Infectious Vaccines Revenue Analysis
      • 4.3 Infectious Vaccines Price Analysis
      • 4.4 Market Concentration Degree

      5 Infectious Vaccines Regional Market Analysis

      • 5.1 Infectious Vaccines Production by Regions
        • 5.1.1 Global Infectious Vaccines Production by Regions
        • 5.1.2 Global Infectious Vaccines Revenue by Regions
      • 5.2 Infectious Vaccines Consumption by Regions
      • 5.3 North America Infectious Vaccines Market Analysis
        • 5.3.1 North America Infectious Vaccines Production
        • 5.3.2 North America Infectious Vaccines Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Infectious Vaccines Import and Export
      • 5.4 Europe Infectious Vaccines Market Analysis
        • 5.4.1 Europe Infectious Vaccines Production
        • 5.4.2 Europe Infectious Vaccines Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Infectious Vaccines Import and Export
      • 5.5 China Infectious Vaccines Market Analysis
        • 5.5.1 China Infectious Vaccines Production
        • 5.5.2 China Infectious Vaccines Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Infectious Vaccines Import and Export
      • 5.6 Japan Infectious Vaccines Market Analysis
        • 5.6.1 Japan Infectious Vaccines Production
        • 5.6.2 Japan Infectious Vaccines Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Infectious Vaccines Import and Export
      • 5.7 Southeast Asia Infectious Vaccines Market Analysis
        • 5.7.1 Southeast Asia Infectious Vaccines Production
        • 5.7.2 Southeast Asia Infectious Vaccines Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Infectious Vaccines Import and Export
      • 5.8 India Infectious Vaccines Market Analysis
        • 5.8.1 India Infectious Vaccines Production
        • 5.8.2 India Infectious Vaccines Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Infectious Vaccines Import and Export

      6 Infectious Vaccines Segment Market Analysis (by Type)

      • 6.1 Global Infectious Vaccines Production by Type
      • 6.2 Global Infectious Vaccines Revenue by Type
      • 6.3 Infectious Vaccines Price by Type

      7 Infectious Vaccines Segment Market Analysis (by Application)

      • 7.1 Global Infectious Vaccines Consumption by Application
      • 7.2 Global Infectious Vaccines Consumption Market Share by Application (2014-2019)

      8 Infectious Vaccines Major Manufacturers Analysis

      • 8.1 CSL Limited (Australia)
        • 8.1.1 CSL Limited (Australia) Infectious Vaccines Production Sites and Area Served
        • 8.1.2 CSL Limited (Australia) Product Introduction, Application and Specification
        • 8.1.3 CSL Limited (Australia) Infectious Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Bavarian Nordic (Denmark)
        • 8.2.1 Bavarian Nordic (Denmark) Infectious Vaccines Production Sites and Area Served
        • 8.2.2 Bavarian Nordic (Denmark) Product Introduction, Application and Specification
        • 8.2.3 Bavarian Nordic (Denmark) Infectious Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 GlaxoSmithKline plc. (U.K.)
        • 8.3.1 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Production Sites and Area Served
        • 8.3.2 GlaxoSmithKline plc. (U.K.) Product Introduction, Application and Specification
        • 8.3.3 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Emergent Bio Solutions Inc. (U.S.)
        • 8.4.1 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Production Sites and Area Served
        • 8.4.2 Emergent Bio Solutions Inc. (U.S.) Product Introduction, Application and Specification
        • 8.4.3 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 MedImmune LLC (U.S.)
        • 8.5.1 MedImmune LLC (U.S.) Infectious Vaccines Production Sites and Area Served
        • 8.5.2 MedImmune LLC (U.S.) Product Introduction, Application and Specification
        • 8.5.3 MedImmune LLC (U.S.) Infectious Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Johnson and Johnson (U.S.)
        • 8.6.1 Johnson and Johnson (U.S.) Infectious Vaccines Production Sites and Area Served
        • 8.6.2 Johnson and Johnson (U.S.) Product Introduction, Application and Specification
        • 8.6.3 Johnson and Johnson (U.S.) Infectious Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Novartis AG (Switzerland)
        • 8.7.1 Novartis AG (Switzerland) Infectious Vaccines Production Sites and Area Served
        • 8.7.2 Novartis AG (Switzerland) Product Introduction, Application and Specification
        • 8.7.3 Novartis AG (Switzerland) Infectious Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Merck and Company (U.S.)
        • 8.8.1 Merck and Company (U.S.) Infectious Vaccines Production Sites and Area Served
        • 8.8.2 Merck and Company (U.S.) Product Introduction, Application and Specification
        • 8.8.3 Merck and Company (U.S.) Infectious Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Sanofi Pasteur (France)
        • 8.9.1 Sanofi Pasteur (France) Infectious Vaccines Production Sites and Area Served
        • 8.9.2 Sanofi Pasteur (France) Product Introduction, Application and Specification
        • 8.9.3 Sanofi Pasteur (France) Infectious Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Pfizer Inc. (U.S.)
        • 8.10.1 Pfizer Inc. (U.S.) Infectious Vaccines Production Sites and Area Served
        • 8.10.2 Pfizer Inc. (U.S.) Product Introduction, Application and Specification
        • 8.10.3 Pfizer Inc. (U.S.) Infectious Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served

      9 Development Trend of Analysis of Infectious Vaccines Market

      • 9.1 Global Infectious Vaccines Market Trend Analysis
        • 9.1.1 Global Infectious Vaccines Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Infectious Vaccines Regional Market Trend
        • 9.2.1 North America Infectious Vaccines Forecast 2019-2025
        • 9.2.2 Europe Infectious Vaccines Forecast 2019-2025
        • 9.2.3 China Infectious Vaccines Forecast 2019-2025
        • 9.2.4 Japan Infectious Vaccines Forecast 2019-2025
        • 9.2.5 Southeast Asia Infectious Vaccines Forecast 2019-2025
        • 9.2.6 India Infectious Vaccines Forecast 2019-2025
      • 9.3 Infectious Vaccines Market Trend (Product Type)
      • 9.4 Infectious Vaccines Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Infectious Vaccines Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        A vaccine is a medical product primarily designed to stimulate antibodies against an infectious disease which help to improve the immunity of the target body.
        Rising consumer awareness regarding health coupled with rising disposable income is expected to propel demand for infectious vaccines over the next seven years. Furthermore, increasing government activities to control epidemic diseases such as polio, camp fever, and swine flu is projected to have impact market growth significantly over the next seven years.

        The global Infectious Vaccines market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Infectious Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Infectious Vaccines market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Infectious Vaccines in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Infectious Vaccines manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        CSL Limited (Australia)
        Bavarian Nordic (Denmark)
        GlaxoSmithKline plc. (U.K.)
        Emergent Bio Solutions Inc. (US)
        MedImmune LLC (US)
        Johnson and Johnson (US)
        Novartis AG (Switzerland)
        Merck and Company (US)
        Sanofi Pasteur (France)
        Pfizer Inc. (US)

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Preventive vaccine
        Therapeutic vaccine

        Segment by Application
        Adults
        Pediatrics

        Buy now